Visual outcomes of toxic optic neuropathy secondary to Ethambutol: A retrospective observational study from India, an endemic country

PURPOSE: Ethambutol (EMB) is one of the first-line drugs used for treating tuberculosis. Vision loss due to optic nerve toxicity is a well-known potential side effect of the drug. Our aim was to evaluate the clinical features and visual outcomes of patients with EMB optic neuropathy (EON). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambika, Selvakumar, Lakshmi, K Padma, Gopal, Madhumita, Noronha, Olma V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675507/
https://www.ncbi.nlm.nih.gov/pubmed/36018127
http://dx.doi.org/10.4103/ijo.IJO_2996_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675507/
https://www.ncbi.nlm.nih.gov/pubmed/36018127
http://dx.doi.org/10.4103/ijo.IJO_2996_21

Ejemplares similares